GeneCast Company
%20.jpg)
GeneCast provides cancer screening, monitoring, precision care and accompanying diagnosis through source technology that amplifies only mutated genes.
Last Funding Type:
Series A
Funding Status:
Early Stage Venture
Headquarters:
South Korea
Founded Date:
42675
Last Funding Date:
43188
Total Funding:
$93.5M
Technology:
preventive
Estimated Revenue:
$1M to $10M
Investors Number:
8
Industry:
Health Care